John K. Scott Jr.

John K. Scott Jr. is a declared insider of Navidea Biopharmaceuticals, Inc. (board member), with filings sourced from SEC (Form 4). Between 22 March 2019 and 27 November 2023, the trades on record add up to 25 filings.

Every open-market trade on record is a purchase: 6 purchases worth €5.0M, and no sale. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 17 share grants.

The median purchase comes to €450k. 1 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 5 December 2023, the filings show a transaction in Navidea Biopharmaceuticals, Inc. The last purchase on record was published on 3 May 2022, which is 1,634 days ago. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.